Evolent Health (EVH) Long-Term Investments (2015 - 2026)

Evolent Health's Long-Term Investments history runs 12 years deep, the most recent figure standing at $9.0 million for Q1 2026.

• On a quarterly basis, Long-Term Investments fell 40.53% year-over-year to $9.0 million in Q1 2026; TTM through Mar 2026 was $9.0 million, a 40.53% decrease from a year earlier, with the FY2025 full-year figure at $2.7 million, down 81.96% from the prior year.
• Long-Term Investments rose to $9.0 million in Q1 2026 per EVH's latest filing, from $2.7 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $17.6 million in Q2 2023 and bottomed at $2.7 million in Q4 2025.
• The 5-year median for Long-Term Investments is $12.5 million (2023), against an average of $11.5 million.
• Across the five-year window, Long-Term Investments surged 164.43% in 2022 and tumbled 81.96% in 2025, its largest moves.
• Year by year, Long-Term Investments stood at $12.5 million in 2022, then soared by 35.28% to $16.9 million in 2023, then fell by 11.06% to $15.0 million in 2024, then tumbled by 81.96% to $2.7 million in 2025, then surged by 230.93% to $9.0 million in 2026.
• Per Business Quant, the three latest EVH Long-Term Investments figures stand at $9.0 million (Q1 2026), $2.7 million (Q4 2025), and $8.9 million (Q3 2025).